Manufacturer: Big Bear Pharmaceuticals (Laos)
Specification: 40mg × 90 tablets
Description:Belzutifan is a potent and selective HIF-2α inhibitor. Hypoxia-inducible factor 2-alpha (HIF-2α) is a critical driver of clear cell renal cell carcinoma (ccRCC). By inhibiting the dimerization of HIF-2α with HIF-1β, belzutifan suppresses tumor cell growth, proliferation, and pathological angiogenesis.







Reviews
There are no reviews yet.